(I) General Concepts Flashcards
ACR choosing wisely
- Do not test antinuclear antibody (ANA) subserologies (anti-dsDNA, anti-Sm, anti-RNP, anti-SS-B,
anti-Scl-70) without a positive ANA and clinical suspicion of immune-mediated disease. Anti-SS-A
may be an exception to this recommendation. - Do not test for Lyme disease as a cause of musculoskeletal symptoms without an exposure history and
appropriate examination findings. - Do not perform an MRI of the peripheral joints to routinely monitor inflammatory arthritis.
- Do not prescribe biologics for RA before a trial of methotrexate (or other conventional nonbiologic
disease-modifying antirheumatic drugs [DMARDs]). - Do not routinely repeat dual-energy X-ray absorptiometry (DXA) scans more often than once every 2 years.
ACR peds choosing wisely
- Do not order autoantibody panels without a positive ANA and evidence of a rheumatic disease.
- Do not test for Lyme disease as a cause of musculoskeletal symptoms without an exposure history and
appropriate examination findings. - Do not routinely perform surveillance joint radiographs to monitor juvenile idiopathic arthritis (JIA)
disease activity. - Do not perform methotrexate toxicity laboratory tests more than every 12 weeks on stable doses.
- Do not repeat a confirmed positive ANA in patients with established JIA or SLE.
NASS choosing wisely
• Do not order MRI of the spine within the first 6 weeks in patients with nonspecific low back pain in the
absence of red flags (trauma, use of corticosteroids, unexplained weight loss, progressive neurologic signs,
age >50 years or
Do NOTS
• Except for anti-dsDNA, do not repeat ANA subserologies in patients with an established connective
tissue disease (CTD) diagnosis.
• Do not perform serial measurements of rheumatoid factor and anti-cyclic citrullinated peptide (CCP) in
patients with documented seropositive RA or serial ANAs in patients with a documented positive ANA
and a CTD diagnosis (e.g., SLE).
• Do not order a human leukocyte antigen (HLA)-B27 unless you suspect an undifferentiated spondyloarthropathy
based on history and examination but have nondiagnostic radiographs.
• Do not check CH50 to follow lupus disease activity.
• Do not order an MRI before ordering plain films in a patient presenting with joint or back pain.
• Do not use intraarticular hyaluronic acid injections for advanced knee OA (i.e., bone on bone).
• Do not treat low bone mass in patients at low risk for fracture (T score > –2.5, no history of fragility
fracture, no steroids, low FRAX).
• Do not order serial yearly plain radiographs in a patient with good clinical (symptoms, examination,
laboratory tests) control of their arthritis unless you are willing to change therapy for minor radiographic
disease progression.
Soft tissue rheumatism.
• Most shoulder pain is periarticular (i.e., a bursitis or tendinitis). Rule out impingement in patients with recurrent
shoulder tendinitis.
• Causes of olecranon or prepatellar bursitis: trauma, infection, gout, rheumatoid arthritis (RA).
• Recalcitrant trochanteric bursitis: rule out leg length discrepancy, hallux rigidus with an abnormal gait,
and lumbar radiculopathy.
• Recalcitrant medial knee pain: rule out anserine bursitis.
• Recalcitrant patellofemoral syndrome: rule out pes planus/hypermobility causing patellar maltracking.
• Due to risk of rupture, do not inject corticosteroids for therapy of Achilles tendinitis/enthesitis.
Use iontophoresis.
- Back pain.
• Patients with significant low back pain cannot do a sit-up.
• Most back pain is nonsurgical.
• Magnetic resonance imaging (MRI)/computed tomography (CT) scans of lumbar spine are abnormal in
30% of patients with no symptoms. Do not attribute a patient’s symptoms to an abnormal radiograph.
• Spinal Phalen’s test is useful to diagnose spinal stenosis. Patients with spinal stenosis have more pain
walking uphill due to spinal extension making the spinal canal smaller. Straight leg raise test and
electromyography/nerve conduction velocities (EMG/NCV) are often normal or nonspecific.
Labs
- Laboratory tests
• Laboratory tests should be used to confirm your clinical diagnosis not make it.
• All patients with a positive rheumatoid factor do not have RA, and all patients with a positive antinuclear
antibody do not have systemic lupus erythematosus (SLE).
• Low complement (C3, C4) levels in a patient with systemic symptoms suggest an immune complexmediated
disease and narrows your diagnosis: SLE, cryoglobulinemia (types II and III), urticarial vasculitis
(HepB and C1q autoantibodies), subacute bacterial endocarditis (SBE), poststreptococcal or membranoproliferative
glomerulonephritis.
• An undetectable (not just low) CH50 activity may indicate a disease associated with a hereditary complement
component deficiency: autoimmune (C1, C4, C2), infection (C3), Neisseria infection (C5 to C8).
• Separating iron deficiency from anemia of chronic disease is best done by measuring the ferritin level. In a
patient with elevated C-reactive protein, a ferritin level of >100 ng/mL rules out iron deficiency.
chronic inflammatory monoarticular arthritis of >8 weeks’ duration
synovial biopsy to rule out
an unusual cause (indolent infection, etc.).
Feel both knees with the back of your hand for temperature differences and compare it to the
lower extremity.
The knee should be cooler than the skin over the tibia. If the knee is warmer then there is ongoing knee
inflammation.
OA
• Cracking knuckles does not cause OA.
• Patients with arthritis can predict the weather due to changes in barometric pressure as weather fronts
move in and out of an area.
• Obesity is the major modifiable risk factor for OA.
• The joints typically involved in primary OA are: distal interphalangeal joints (DIPs) (Heberden’s nodes),
proximal interphalangeal joints (PIPs) (Bouchard’s nodes), first carpometacarpal (CMC), hips, knees, first
metatarsophalangeal joint (MTP), the cervical and lumbosacral spine.
• Patients with OA affecting joints not normally affected by primary OA (i.e., metacarpophalangeals,
wrists, elbows, shoulder, ankles) need to be evaluated for secondary causes of OA (i.e., calcium pyrophosphate
disease [CPPD], metabolic diseases, others).
• Erosive OA is an inflammatory subset of OA (10% of patients) primarily affecting the hands (DIPs, PIPs,
first CMC) and causing the “seagull” sign on radiographs. It is more disabling than primary OA
Knee and hip osteoarthritis
• Over 50% of patients over 65 years have radiographic knee OA but only 25% have symptoms. Do not rely
on the radiograph to make the diagnosis of the cause of knee pain.
• Recurrent, large, noninflammatory knee effusions are frequently due to an internal derangement
(e.g., meniscal tear).
• Nonsteroidal antiinflammatory drugs (NSAIDs) are better than acetaminophen if a patient has an
effusion, which indicates more inflammation (wet OA).
• Intraarticular corticosteroids also work and are cheaper than viscosupplementation (hyaluronic acid),
especially in patients with a knee effusion.
• Drain any knee effusion before giving viscosupplementation or corticosteroids.
• Incidental and asymptomatic meniscal tears are common (>20%) in patients with knee OA. Meniscal
repair and/or arthroscopic debridement and washout are not helpful unless there are signs of locking.
• Femoroacetabular impingement is a common cause of hip pain in young patients who develop early OA.
Seronegative RA is a difficult diagnosis in patients without erosions on radiographs
Always consider CPPD in these patients.
Treat to target
Early therapy with the goal of low disease activity is essential to RA (and psoriatic arthritis) therapy.
• It does not matter which disease activity measure you use (e.g., Clinical Disease Activity Index [CDAI],
Routine Assessment of Patient Index Data 3 [RAPID3], etc.), just pick one and use it to document if your
therapy is achieving low disease activity or remission.
Systemic sclerosis.
• New onset hypertension and schistocytes on blood smear in a diffuse systemic sclerosis patient heralds
the onset of scleroderma renal crisis, especially in a patient who is anti-RNA polymerase III positive.
Angiotensin-converting enzyme (ACE) inhibitors work better than angiotensin receptor blockers (ARBs).
• A %forced vital capacity (FVC)/%DLCO ratio of >1.6 predicts pulmonary hypertension.
• An FVC <70% and a high resolution CT scan of the lung showing >20% fibrosis predicts progression of
scleroderma-related interstitial lung disease.
- Statins can cause myalgias without an elevated CPK, myalgias with an elevated CPK, and a
necrotizing myopathy with anti-HMGCoA reductase antibodies.
- Myalgias can be improved with coenzyme Q.
* Hydrophilic statins (pravachol, rosuvastatin) cause less myopathy than lipophilic statins (simvastatin, etc.).
Hydrophilic statins
pravachol, rosuvastatin
lipophilic statins
simvastatin, etc
APL labs:
lupus anticoagulant,
anticardiolipin antibodies,
anti-β2glycoprotein I antibodies
All patients with significantly positive aPLabs should have prophylactic anticoagulation if they
undergo a surgical procedure and/or following pregnancy delivery even if they have never had
a clot.
Surgical release of tissue factor is the second hit in the “two hit” hypothesis for clots in aPLab positive patients.
• Always have placenta assessed (clinically and/or pathologically) for evidence of damage in patients with
aPLab regardless of pregnancy outcome. If placental damage is present, the patient needs anticoagulation
during any future pregnancy.
Still’s disease should be considered in any patient with a quotidian fever (decreases to normal
or below once a day), rash, and joint pain.
A ferritin level >1000 ng/mL supports the diagnosis.
(PMR) patients should respond completely to 20 mg daily of
prednisone
and normalize their erythrocyte sedimentation rate (ESR) within a month
The presence of fever or failure to respond to prednisone clinically and serologically suggests giant cell
arteritis or another diagnosis such as lymphoma.
After ruling out infection and malignancy, consider vasculitis in any patient with multisystem
disease who has an ESR >100 mm/hour and a C-reactive protein >10 times the upper limit of
normal.
• The primary vasculitides (i.e., not due to another disease) are not associated with positive serologies
(ANA, rheumatoid factor (RF), low complements), neutropenia, or thrombocytopenia. If one of these are
present, consider another diagnosis.
Listen for subclavian bruits in all patients suspected of having GCA as it may be their only
clinical
finding
Large vessel involvement puts them at increased (17×) risk for aortic dissections and aneurysms.
Do not delay starting prednisone in a patient suspected to have GCA
GCA.
It will not affect the temporal artery biopsy results for at least a week.
When the suspected diagnosis is primary vasculitis of the central nervous system (CNS), it
probably is incorrect
Rule out other diseases with a brain biopsy
GPA or Wegener’s) should be considered in any adult who
develops otitis media.
GPA predominantly affects the upper and lower respiratory tracts and kidneys and is associated with
proteinase 3-antineutrophil cytoplasmic antibody (PR3-ANCA).
Skin biopsy in Henoch–Schonlein purpura (HSP) shows leukocytoclastic vasculitis with IgA
deposition in vessel walls on direct immunofluorescence
HSP is the most common small vessel vasculitis in childhood.
Most patients with mixed cryoglobulinemia will present with palpable purpura, arthralgia, and
weakness/myalgias (Meltzer’s triad).
A positive rheumatoid factor and low C4 (“poor man’s cryo”) level supports the diagnosis before the
cryoglobulin
screen has returned.
Meltzer’s triad
palpable purpura, arthralgia, and
weakness/myalgias
(ptx with mixed cryo)
Even though HLA-B27 increases a person’s risk of developing a spondyloarthropathy 50 times,
only 1 out of every 50 (2%) HLA-B27 positive individuals without a family history will develop
ankylosing spondylitis during their lifetime
If the person has a family history the risk increases to one in five (20%).
• Nearly 50% of HLA-B27 positive patients with recurrent unilateral anterior uveitis have or will develop
an underlying spondyloarthropathy
A patient less than 40 years old with three out of four of the following has a high likelihood of
having inflammatory back pain:
(1) morning stiffness of at least 30 minutes; (2) improvement of
back pain with exercise but not rest;
(3) awakening because of back pain and stiffness during
second half of the night only;
(4) alternating buttock pain.
- Inflammatory arthritis is most likely to occur in Crohn’s disease patients with extensive colonic
involvement
These patients may present with prominent arthritis but few gastrointestinal symptoms